FDA approves drug to treat hypertension

The Food and Drug Administration approved Jubilant Life Sciences' new drug for the treatment of hypertension.

Telmisartan tablets represent a generic version of Boehringer Ingelheim Pharmaceuticals' Micardis tablets.

As of June 30, India-based Jubilant holds 70 drug applications filed through the FDA, 44 of which have been approved.

More articles on supply chain:

Medical device, drug recalls soar in Q2
AMA urges Mylan to lower cost of EpiPens
Mylan vows to reduce patient costs in light of EpiPen pricing scandal

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars